mRNA Therapy Market, Global Outlook and Forecast 2022-2028

January 2022 | 62 pages | ID: MF7D51C5FD74EN
Market Monitor Global

Abstracts

By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.

This report contains market size and forecasts of mRNA Therapy in Global, including the following market information:

Global mRNA Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global mRNA Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of mRNA Therapy include Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca and CureVac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global mRNA Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global mRNA Therapy Market Segment Percentages, by Type, 2021 (%)

• Vaccine
• Drugs

Global mRNA Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global mRNA Therapy Market Segment Percentages, by Application, 2021 (%)

• mRNA Targeted Delivery in vivo
• Genetically Modified T cells
• Transforming Nanoparticles to Develop Immunotherapy for Cancer
• Small Molecule Drugs Discovery

Global mRNA Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global mRNA Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies mRNA Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies mRNA Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Moderna
• BioNTech
• Pfizer
• Arcturus Therapeutics Holdings Inc.
• Astrazeneca
• CureVac

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 mRNA Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global mRNA Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MRNA THERAPY OVERALL MARKET SIZE

2.1 Global mRNA Therapy Market Size: 2021 VS 2028
2.2 Global mRNA Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top mRNA Therapy Players in Global Market
3.2 Top Global mRNA Therapy Companies Ranked by Revenue
3.3 Global mRNA Therapy Revenue by Companies
3.4 Top 3 and Top 5 mRNA Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies mRNA Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Therapy Players in Global Market
  3.6.1 List of Global Tier 1 mRNA Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 mRNA Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global mRNA Therapy Market Size Markets, 2021 & 2028
  4.1.2 Vaccine
  4.1.3 Drugs
4.2 By Type - Global mRNA Therapy Revenue & Forecasts
  4.2.1 By Type - Global mRNA Therapy Revenue, 2017-2022
  4.2.2 By Type - Global mRNA Therapy Revenue, 2023-2028
  4.2.3 By Type - Global mRNA Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global mRNA Therapy Market Size, 2021 & 2028
  5.1.2 mRNA Targeted Delivery in vivo
  5.1.3 Genetically Modified T cells
  5.1.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
  5.1.5 Small Molecule Drugs Discovery
5.2 By Application - Global mRNA Therapy Revenue & Forecasts
  5.2.1 By Application - Global mRNA Therapy Revenue, 2017-2022
  5.2.2 By Application - Global mRNA Therapy Revenue, 2023-2028
  5.2.3 By Application - Global mRNA Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global mRNA Therapy Market Size, 2021 & 2028
6.2 By Region - Global mRNA Therapy Revenue & Forecasts
  6.2.1 By Region - Global mRNA Therapy Revenue, 2017-2022
  6.2.2 By Region - Global mRNA Therapy Revenue, 2023-2028
  6.2.3 By Region - Global mRNA Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America mRNA Therapy Revenue, 2017-2028
  6.3.2 US mRNA Therapy Market Size, 2017-2028
  6.3.3 Canada mRNA Therapy Market Size, 2017-2028
  6.3.4 Mexico mRNA Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe mRNA Therapy Revenue, 2017-2028
  6.4.2 Germany mRNA Therapy Market Size, 2017-2028
  6.4.3 France mRNA Therapy Market Size, 2017-2028
  6.4.4 U.K. mRNA Therapy Market Size, 2017-2028
  6.4.5 Italy mRNA Therapy Market Size, 2017-2028
  6.4.6 Russia mRNA Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries mRNA Therapy Market Size, 2017-2028
  6.4.8 Benelux mRNA Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia mRNA Therapy Revenue, 2017-2028
  6.5.2 China mRNA Therapy Market Size, 2017-2028
  6.5.3 Japan mRNA Therapy Market Size, 2017-2028
  6.5.4 South Korea mRNA Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia mRNA Therapy Market Size, 2017-2028
  6.5.6 India mRNA Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America mRNA Therapy Revenue, 2017-2028
  6.6.2 Brazil mRNA Therapy Market Size, 2017-2028
  6.6.3 Argentina mRNA Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa mRNA Therapy Revenue, 2017-2028
  6.7.2 Turkey mRNA Therapy Market Size, 2017-2028
  6.7.3 Israel mRNA Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia mRNA Therapy Market Size, 2017-2028
  6.7.5 UAE mRNA Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Moderna
  7.1.1 Moderna Corporate Summary
  7.1.2 Moderna Business Overview
  7.1.3 Moderna mRNA Therapy Major Product Offerings
  7.1.4 Moderna mRNA Therapy Revenue in Global Market (2017-2022)
  7.1.5 Moderna Key News
7.2 BioNTech
  7.2.1 BioNTech Corporate Summary
  7.2.2 BioNTech Business Overview
  7.2.3 BioNTech mRNA Therapy Major Product Offerings
  7.2.4 BioNTech mRNA Therapy Revenue in Global Market (2017-2022)
  7.2.5 BioNTech Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer mRNA Therapy Major Product Offerings
  7.3.4 Pfizer mRNA Therapy Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Arcturus Therapeutics Holdings Inc.
  7.4.1 Arcturus Therapeutics Holdings Inc. Corporate Summary
  7.4.2 Arcturus Therapeutics Holdings Inc. Business Overview
  7.4.3 Arcturus Therapeutics Holdings Inc. mRNA Therapy Major Product Offerings
  7.4.4 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue in Global Market (2017-2022)
  7.4.5 Arcturus Therapeutics Holdings Inc. Key News
7.5 Astrazeneca
  7.5.1 Astrazeneca Corporate Summary
  7.5.2 Astrazeneca Business Overview
  7.5.3 Astrazeneca mRNA Therapy Major Product Offerings
  7.5.4 Astrazeneca mRNA Therapy Revenue in Global Market (2017-2022)
  7.5.5 Astrazeneca Key News
7.6 CureVac
  7.6.1 CureVac Corporate Summary
  7.6.2 CureVac Business Overview
  7.6.3 CureVac mRNA Therapy Major Product Offerings
  7.6.4 CureVac mRNA Therapy Revenue in Global Market (2017-2022)
  7.6.5 CureVac Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. mRNA Therapy Market Opportunities & Trends in Global Market
Table 2. mRNA Therapy Market Drivers in Global Market
Table 3. mRNA Therapy Market Restraints in Global Market
Table 4. Key Players of mRNA Therapy in Global Market
Table 5. Top mRNA Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global mRNA Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global mRNA Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies mRNA Therapy Product Type
Table 9. List of Global Tier 1 mRNA Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global mRNA Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - mRNA Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - mRNA Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global mRNA Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - mRNA Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - mRNA Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global mRNA Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global mRNA Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global mRNA Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America mRNA Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America mRNA Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe mRNA Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe mRNA Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia mRNA Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia mRNA Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America mRNA Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America mRNA Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa mRNA Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa mRNA Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Moderna Corporate Summary
Table 31. Moderna mRNA Therapy Product Offerings
Table 32. Moderna mRNA Therapy Revenue (US$, Mn), (2017-2022)
Table 33. BioNTech Corporate Summary
Table 34. BioNTech mRNA Therapy Product Offerings
Table 35. BioNTech mRNA Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer mRNA Therapy Product Offerings
Table 38. Pfizer mRNA Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Arcturus Therapeutics Holdings Inc. Corporate Summary
Table 40. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product Offerings
Table 41. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Astrazeneca Corporate Summary
Table 43. Astrazeneca mRNA Therapy Product Offerings
Table 44. Astrazeneca mRNA Therapy Revenue (US$, Mn), (2017-2022)
Table 45. CureVac Corporate Summary
Table 46. CureVac mRNA Therapy Product Offerings
Table 47. CureVac mRNA Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. mRNA Therapy Segment by Type in 2021
Figure 2. mRNA Therapy Segment by Application in 2021
Figure 3. Global mRNA Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global mRNA Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global mRNA Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Therapy Revenue in 2021
Figure 8. By Type - Global mRNA Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global mRNA Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global mRNA Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America mRNA Therapy Revenue Market Share, 2017-2028
Figure 12. US mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe mRNA Therapy Revenue Market Share, 2017-2028
Figure 16. Germany mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia mRNA Therapy Revenue Market Share, 2017-2028
Figure 24. China mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America mRNA Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa mRNA Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE mRNA Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Moderna mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioNTech mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astrazeneca mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CureVac mRNA Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)